Aptus Pharma Limited (BOM:544529)
India
· Delayed Price · Currency is INR 285.30
+13.55 (4.99%)
At close: Mar 9, 2026
Aptus Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 142.82 | 52.14 | 9.14 | 5.37 | 2.61 | 0.75 | Upgrade
|
| Cash & Short-Term Investments | 142.82 | 52.14 | 9.14 | 5.37 | 2.61 | 0.75 | Upgrade
|
| Cash Growth | 2561.35% | 470.20% | 70.41% | 105.97% | 249.19% | -16.84% | Upgrade
|
| Accounts Receivable | 100.7 | 56.39 | 33.54 | 23.98 | 18.5 | 15.64 | Upgrade
|
| Receivables | 125.56 | 60.09 | 37.82 | 27.65 | 18.86 | 15.92 | Upgrade
|
| Inventory | 103.52 | 70.58 | 34.26 | 22.99 | 13.94 | 7.82 | Upgrade
|
| Prepaid Expenses | - | 1.31 | 0.37 | 0.23 | 0.2 | 0.09 | Upgrade
|
| Other Current Assets | - | 13.24 | 1.63 | 0.29 | 0.65 | 0.06 | Upgrade
|
| Total Current Assets | 371.89 | 197.36 | 83.22 | 56.52 | 36.25 | 24.64 | Upgrade
|
| Property, Plant & Equipment | 11.44 | 9.63 | 6.17 | 5.14 | 3.47 | 1.28 | Upgrade
|
| Long-Term Investments | - | - | 10.06 | - | - | - | Upgrade
|
| Other Intangible Assets | 0.39 | 0.28 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.85 | 0.74 | 0.56 | 0.36 | 0.19 | 0.13 | Upgrade
|
| Other Long-Term Assets | 11.31 | 11.2 | 0.09 | 0.09 | 0.09 | 0.09 | Upgrade
|
| Total Assets | 395.87 | 219.2 | 100.1 | 62.11 | 40 | 26.14 | Upgrade
|
| Accounts Payable | 59.29 | 13.09 | 18.45 | 25.78 | 9.11 | 8.5 | Upgrade
|
| Accrued Expenses | - | 11.9 | 2.63 | 1.51 | 0.32 | 0.88 | Upgrade
|
| Short-Term Debt | - | 66.37 | 9.91 | - | - | 3.18 | Upgrade
|
| Current Portion of Long-Term Debt | 60.02 | 11 | 3.57 | 2.05 | 1.92 | 2.66 | Upgrade
|
| Current Income Taxes Payable | - | 11.17 | 3.14 | 1.05 | 0.51 | 0.29 | Upgrade
|
| Other Current Liabilities | 35.71 | 7.31 | 3.26 | 0.7 | 8.96 | 0.89 | Upgrade
|
| Total Current Liabilities | 155.02 | 120.84 | 40.97 | 31.09 | 20.81 | 16.4 | Upgrade
|
| Long-Term Debt | 21.34 | 26.2 | 39.6 | 20.07 | 10.67 | 7.48 | Upgrade
|
| Pension & Post-Retirement Benefits | 2.5 | 2.5 | - | - | - | - | Upgrade
|
| Total Liabilities | 178.85 | 149.54 | 80.56 | 51.16 | 31.48 | 23.88 | Upgrade
|
| Common Stock | 68.6 | 50 | 3 | 3 | 3 | 1.25 | Upgrade
|
| Additional Paid-In Capital | - | 8 | 3.5 | 3.5 | - | - | Upgrade
|
| Retained Earnings | - | 11.66 | 13.04 | 4.44 | 5.52 | 1.01 | Upgrade
|
| Shareholders' Equity | 217.02 | 69.66 | 19.54 | 10.94 | 8.52 | 2.26 | Upgrade
|
| Total Liabilities & Equity | 395.87 | 219.2 | 100.1 | 62.11 | 40 | 26.14 | Upgrade
|
| Total Debt | 81.35 | 103.57 | 53.08 | 22.12 | 12.58 | 13.33 | Upgrade
|
| Net Cash (Debt) | 61.46 | -51.43 | -43.94 | -16.75 | -9.98 | -12.58 | Upgrade
|
| Net Cash Per Share | 8.75 | -10.57 | -29.29 | -22.94 | -13.66 | -20.13 | Upgrade
|
| Filing Date Shares Outstanding | 5.05 | 5 | 1.5 | 1.5 | 1.5 | 0.63 | Upgrade
|
| Total Common Shares Outstanding | 5.05 | 5 | 1.5 | 1.5 | 1.5 | 0.63 | Upgrade
|
| Working Capital | 216.87 | 76.53 | 42.26 | 25.43 | 15.44 | 8.23 | Upgrade
|
| Book Value Per Share | 42.97 | 13.93 | 13.03 | 7.30 | 5.68 | 3.61 | Upgrade
|
| Tangible Book Value | 216.63 | 69.39 | 19.54 | 10.94 | 8.51 | 2.25 | Upgrade
|
| Tangible Book Value Per Share | 42.89 | 13.88 | 13.03 | 7.30 | 5.68 | 3.60 | Upgrade
|
| Buildings | - | 0.88 | - | - | - | - | Upgrade
|
| Machinery | - | 17.35 | 12.15 | 8.99 | 5.52 | 2.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.